Theriva Biologics, Inc. Profile Avatar - Palmy Investing

Theriva Biologics, Inc.

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …

Biotechnology
US, Rockville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Theriva Biologics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Theriva Biologics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Theriva Biologics, Inc..

End of TOVX's Analysis
CIK: 894158 CUSIP: - ISIN: US87164U4094 LEI: - UEI: -
Secondary Listings
TOVX has no secondary listings inside our databases.